ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Biothrax (Anthrax Vaccine) Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-34D7974
Home | Market Reports | Health| Pharmacy
Global Biothrax Anthrax Vaccine Market Insights Forecast to 2028
BUY CHAPTERS

Global Biothrax (Anthrax Vaccine) Market Research Report 2025

Code: QYRE-Auto-34D7974
Report
July 2025
Pages:111
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merial 
Merck
Zoetis Inc
Bayer Sanidad Animal
Colorado Serum
PharmAthene
Tiankang
Biogénesis-Bago
CAVAC
Rosenbusch
Agrovet
Vecol
CVCRI
IVPM
Prondil
CDV
Indian Immunologicals
Botswana Vaccine Institute
Ceva Santé Animale
Intervac
JOVAC

Biothrax (Anthrax Vaccine) Market Size

The global market for Biothrax (Anthrax Vaccine) was valued at US$ 727 million in the year 2024 and is projected to reach a revised size of US$ 1211 million by 2031, growing at a CAGR of 7.7% during the forecast period.

Biothrax (Anthrax Vaccine) Market

Biothrax (Anthrax Vaccine) Market

Anthrax is a serious disease that can affect both animals and humans. It is caused by bacteria called Bacillus anthracis. People can get anthrax from contact with infected animals, wool, meat, or hides.Anthrax vaccine protects against anthrax disease. Anthrax vaccine was licensed in 1970.Based on limited but sound evidence, the vaccine protects against both cutaneous (skin) and inhalation anthrax. Biothrax, commonly known as the anthrax vaccine, is a medical countermeasure developed to protect individuals from anthrax, a potentially lethal bacterial infection caused by Bacillus anthracis. The vaccine is used primarily for military personnel, laboratory workers, and individuals at high risk of exposure to anthrax spores. It stimulates the immune system to produce antibodies against the anthrax toxin, preventing the progression of the disease if exposed to the bacteria. Biothrax is administered through a series of doses and boosters and is a critical component of preparedness against bioterrorism threats involving anthrax.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Biothrax (Anthrax Vaccine), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biothrax (Anthrax Vaccine).
The Biothrax (Anthrax Vaccine) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biothrax (Anthrax Vaccine) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biothrax (Anthrax Vaccine) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Biothrax (Anthrax Vaccine) Market Report

Report Metric Details
Report Name Biothrax (Anthrax Vaccine) Market
Accounted market size in year US$ 727 million
Forecasted market size in 2031 US$ 1211 million
CAGR 7.7%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Human Use
  • Animal Use
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merial, Merck, Zoetis, Bayer Sanidad Animal, Colorado Serum, PharmAthene, Tiankang, Biogénesis-Bago, CAVAC, Rosenbusch, Agrovet, Vecol, CVCRI, IVPM, Prondil, CDV, Indian Immunologicals, Botswana Vaccine Institute, Ceva Santé Animale, Intervac, JOVAC
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Biothrax (Anthrax Vaccine) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Biothrax (Anthrax Vaccine) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Biothrax (Anthrax Vaccine) Market growing?

Ans: The Biothrax (Anthrax Vaccine) Market witnessing a CAGR of 7.7% during the forecast period 2025-2031.

What is the Biothrax (Anthrax Vaccine) Market size in 2031?

Ans: The Biothrax (Anthrax Vaccine) Market size in 2031 will be US$ 1211 million.

Who are the main players in the Biothrax (Anthrax Vaccine) Market report?

Ans: The main players in the Biothrax (Anthrax Vaccine) Market are Merial, Merck, Zoetis, Bayer Sanidad Animal, Colorado Serum, PharmAthene, Tiankang, Biogénesis-Bago, CAVAC, Rosenbusch, Agrovet, Vecol, CVCRI, IVPM, Prondil, CDV, Indian Immunologicals, Botswana Vaccine Institute, Ceva Santé Animale, Intervac, JOVAC

What are the Application segmentation covered in the Biothrax (Anthrax Vaccine) Market report?

Ans: The Applications covered in the Biothrax (Anthrax Vaccine) Market report are Human Use, Animal Use

What are the Type segmentation covered in the Biothrax (Anthrax Vaccine) Market report?

Ans: The Types covered in the Biothrax (Anthrax Vaccine) Market report are Live Vaccines, Cell Free PA Vaccines

Recommended Reports

Anthrax & Bacterial Vaccines

Technological Vaccine Trends

Human & Veterinary Vaccines

1 Biothrax (Anthrax Vaccine) Market Overview
1.1 Product Definition
1.2 Biothrax (Anthrax Vaccine) by Type
1.2.1 Global Biothrax (Anthrax Vaccine) Market Value Comparison by Type (2024 VS 2031)
1.2.2 Live Vaccines
1.2.3 Cell Free PA Vaccines
1.3 Biothrax (Anthrax Vaccine) by Application
1.3.1 Global Biothrax (Anthrax Vaccine) Market Value by Application (2024 VS 2031)
1.3.2 Human Use
1.3.3 Animal Use
1.4 Global Biothrax (Anthrax Vaccine) Market Size Estimates and Forecasts
1.4.1 Global Biothrax (Anthrax Vaccine) Revenue 2020-2031
1.4.2 Global Biothrax (Anthrax Vaccine) Sales 2020-2031
1.4.3 Global Biothrax (Anthrax Vaccine) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Biothrax (Anthrax Vaccine) Market Competition by Manufacturers
2.1 Global Biothrax (Anthrax Vaccine) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Biothrax (Anthrax Vaccine) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Biothrax (Anthrax Vaccine) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Biothrax (Anthrax Vaccine), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Biothrax (Anthrax Vaccine), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Biothrax (Anthrax Vaccine), Product Type & Application
2.7 Global Key Manufacturers of Biothrax (Anthrax Vaccine), Date of Enter into This Industry
2.8 Global Biothrax (Anthrax Vaccine) Market Competitive Situation and Trends
2.8.1 Global Biothrax (Anthrax Vaccine) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Biothrax (Anthrax Vaccine) Players Market Share by Revenue
2.8.3 Global Biothrax (Anthrax Vaccine) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Biothrax (Anthrax Vaccine) Market Scenario by Region
3.1 Global Biothrax (Anthrax Vaccine) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Biothrax (Anthrax Vaccine) Sales by Region: 2020-2031
3.2.1 Global Biothrax (Anthrax Vaccine) Sales by Region: 2020-2025
3.2.2 Global Biothrax (Anthrax Vaccine) Sales by Region: 2026-2031
3.3 Global Biothrax (Anthrax Vaccine) Revenue by Region: 2020-2031
3.3.1 Global Biothrax (Anthrax Vaccine) Revenue by Region: 2020-2025
3.3.2 Global Biothrax (Anthrax Vaccine) Revenue by Region: 2026-2031
3.4 North America Biothrax (Anthrax Vaccine) Market Facts & Figures by Country
3.4.1 North America Biothrax (Anthrax Vaccine) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Biothrax (Anthrax Vaccine) Sales by Country (2020-2031)
3.4.3 North America Biothrax (Anthrax Vaccine) Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Biothrax (Anthrax Vaccine) Market Facts & Figures by Country
3.5.1 Europe Biothrax (Anthrax Vaccine) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Biothrax (Anthrax Vaccine) Sales by Country (2020-2031)
3.5.3 Europe Biothrax (Anthrax Vaccine) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Biothrax (Anthrax Vaccine) Market Facts & Figures by Region
3.6.1 Asia Pacific Biothrax (Anthrax Vaccine) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Biothrax (Anthrax Vaccine) Sales by Region (2020-2031)
3.6.3 Asia Pacific Biothrax (Anthrax Vaccine) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Biothrax (Anthrax Vaccine) Market Facts & Figures by Country
3.7.1 Latin America Biothrax (Anthrax Vaccine) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Biothrax (Anthrax Vaccine) Sales by Country (2020-2031)
3.7.3 Latin America Biothrax (Anthrax Vaccine) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Biothrax (Anthrax Vaccine) Market Facts & Figures by Country
3.8.1 Middle East and Africa Biothrax (Anthrax Vaccine) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Biothrax (Anthrax Vaccine) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Biothrax (Anthrax Vaccine) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Biothrax (Anthrax Vaccine) Sales by Type (2020-2031)
4.1.1 Global Biothrax (Anthrax Vaccine) Sales by Type (2020-2025)
4.1.2 Global Biothrax (Anthrax Vaccine) Sales by Type (2026-2031)
4.1.3 Global Biothrax (Anthrax Vaccine) Sales Market Share by Type (2020-2031)
4.2 Global Biothrax (Anthrax Vaccine) Revenue by Type (2020-2031)
4.2.1 Global Biothrax (Anthrax Vaccine) Revenue by Type (2020-2025)
4.2.2 Global Biothrax (Anthrax Vaccine) Revenue by Type (2026-2031)
4.2.3 Global Biothrax (Anthrax Vaccine) Revenue Market Share by Type (2020-2031)
4.3 Global Biothrax (Anthrax Vaccine) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Biothrax (Anthrax Vaccine) Sales by Application (2020-2031)
5.1.1 Global Biothrax (Anthrax Vaccine) Sales by Application (2020-2025)
5.1.2 Global Biothrax (Anthrax Vaccine) Sales by Application (2026-2031)
5.1.3 Global Biothrax (Anthrax Vaccine) Sales Market Share by Application (2020-2031)
5.2 Global Biothrax (Anthrax Vaccine) Revenue by Application (2020-2031)
5.2.1 Global Biothrax (Anthrax Vaccine) Revenue by Application (2020-2025)
5.2.2 Global Biothrax (Anthrax Vaccine) Revenue by Application (2026-2031)
5.2.3 Global Biothrax (Anthrax Vaccine) Revenue Market Share by Application (2020-2031)
5.3 Global Biothrax (Anthrax Vaccine) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merial
6.1.1 Merial Company Information
6.1.2 Merial Description and Business Overview
6.1.3 Merial Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merial Biothrax (Anthrax Vaccine) Product Portfolio
6.1.5 Merial Recent Developments/Updates
6.2 Merck
6.2.1 Merck Company Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Merck Biothrax (Anthrax Vaccine) Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Zoetis
6.3.1 Zoetis Company Information
6.3.2 Zoetis Description and Business Overview
6.3.3 Zoetis Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Zoetis Biothrax (Anthrax Vaccine) Product Portfolio
6.3.5 Zoetis Recent Developments/Updates
6.4 Bayer Sanidad Animal
6.4.1 Bayer Sanidad Animal Company Information
6.4.2 Bayer Sanidad Animal Description and Business Overview
6.4.3 Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Product Portfolio
6.4.5 Bayer Sanidad Animal Recent Developments/Updates
6.5 Colorado Serum
6.5.1 Colorado Serum Company Information
6.5.2 Colorado Serum Description and Business Overview
6.5.3 Colorado Serum Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Colorado Serum Biothrax (Anthrax Vaccine) Product Portfolio
6.5.5 Colorado Serum Recent Developments/Updates
6.6 PharmAthene
6.6.1 PharmAthene Company Information
6.6.2 PharmAthene Description and Business Overview
6.6.3 PharmAthene Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 PharmAthene Biothrax (Anthrax Vaccine) Product Portfolio
6.6.5 PharmAthene Recent Developments/Updates
6.7 Tiankang
6.7.1 Tiankang Company Information
6.7.2 Tiankang Description and Business Overview
6.7.3 Tiankang Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Tiankang Biothrax (Anthrax Vaccine) Product Portfolio
6.7.5 Tiankang Recent Developments/Updates
6.8 Biogénesis-Bago
6.8.1 Biogénesis-Bago Company Information
6.8.2 Biogénesis-Bago Description and Business Overview
6.8.3 Biogénesis-Bago Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Biogénesis-Bago Biothrax (Anthrax Vaccine) Product Portfolio
6.8.5 Biogénesis-Bago Recent Developments/Updates
6.9 CAVAC
6.9.1 CAVAC Company Information
6.9.2 CAVAC Description and Business Overview
6.9.3 CAVAC Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2020-2025)
6.9.4 CAVAC Biothrax (Anthrax Vaccine) Product Portfolio
6.9.5 CAVAC Recent Developments/Updates
6.10 Rosenbusch
6.10.1 Rosenbusch Company Information
6.10.2 Rosenbusch Description and Business Overview
6.10.3 Rosenbusch Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Rosenbusch Biothrax (Anthrax Vaccine) Product Portfolio
6.10.5 Rosenbusch Recent Developments/Updates
6.11 Agrovet
6.11.1 Agrovet Company Information
6.11.2 Agrovet Description and Business Overview
6.11.3 Agrovet Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Agrovet Biothrax (Anthrax Vaccine) Product Portfolio
6.11.5 Agrovet Recent Developments/Updates
6.12 Vecol
6.12.1 Vecol Company Information
6.12.2 Vecol Description and Business Overview
6.12.3 Vecol Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Vecol Biothrax (Anthrax Vaccine) Product Portfolio
6.12.5 Vecol Recent Developments/Updates
6.13 CVCRI
6.13.1 CVCRI Company Information
6.13.2 CVCRI Description and Business Overview
6.13.3 CVCRI Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2020-2025)
6.13.4 CVCRI Biothrax (Anthrax Vaccine) Product Portfolio
6.13.5 CVCRI Recent Developments/Updates
6.14 IVPM
6.14.1 IVPM Company Information
6.14.2 IVPM Description and Business Overview
6.14.3 IVPM Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2020-2025)
6.14.4 IVPM Biothrax (Anthrax Vaccine) Product Portfolio
6.14.5 IVPM Recent Developments/Updates
6.15 Prondil
6.15.1 Prondil Company Information
6.15.2 Prondil Description and Business Overview
6.15.3 Prondil Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Prondil Biothrax (Anthrax Vaccine) Product Portfolio
6.15.5 Prondil Recent Developments/Updates
6.16 CDV
6.16.1 CDV Company Information
6.16.2 CDV Description and Business Overview
6.16.3 CDV Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2020-2025)
6.16.4 CDV Biothrax (Anthrax Vaccine) Product Portfolio
6.16.5 CDV Recent Developments/Updates
6.17 Indian Immunologicals
6.17.1 Indian Immunologicals Company Information
6.17.2 Indian Immunologicals Description and Business Overview
6.17.3 Indian Immunologicals Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Indian Immunologicals Biothrax (Anthrax Vaccine) Product Portfolio
6.17.5 Indian Immunologicals Recent Developments/Updates
6.18 Botswana Vaccine Institute
6.18.1 Botswana Vaccine Institute Company Information
6.18.2 Botswana Vaccine Institute Description and Business Overview
6.18.3 Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Product Portfolio
6.18.5 Botswana Vaccine Institute Recent Developments/Updates
6.19 Ceva Santé Animale
6.19.1 Ceva Santé Animale Company Information
6.19.2 Ceva Santé Animale Description and Business Overview
6.19.3 Ceva Santé Animale Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Ceva Santé Animale Biothrax (Anthrax Vaccine) Product Portfolio
6.19.5 Ceva Santé Animale Recent Developments/Updates
6.20 Intervac
6.20.1 Intervac Company Information
6.20.2 Intervac Description and Business Overview
6.20.3 Intervac Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Intervac Biothrax (Anthrax Vaccine) Product Portfolio
6.20.5 Intervac Recent Developments/Updates
6.21 JOVAC
6.21.1 JOVAC Company Information
6.21.2 JOVAC Description and Business Overview
6.21.3 JOVAC Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2020-2025)
6.21.4 JOVAC Biothrax (Anthrax Vaccine) Product Portfolio
6.21.5 JOVAC Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Biothrax (Anthrax Vaccine) Industry Chain Analysis
7.2 Biothrax (Anthrax Vaccine) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Biothrax (Anthrax Vaccine) Production Mode & Process Analysis
7.4 Biothrax (Anthrax Vaccine) Sales and Marketing
7.4.1 Biothrax (Anthrax Vaccine) Sales Channels
7.4.2 Biothrax (Anthrax Vaccine) Distributors
7.5 Biothrax (Anthrax Vaccine) Customer Analysis
8 Biothrax (Anthrax Vaccine) Market Dynamics
8.1 Biothrax (Anthrax Vaccine) Industry Trends
8.2 Biothrax (Anthrax Vaccine) Market Drivers
8.3 Biothrax (Anthrax Vaccine) Market Challenges
8.4 Biothrax (Anthrax Vaccine) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Merial 
Merck
Zoetis Inc
Bayer Sanidad Animal
Colorado Serum
PharmAthene
Tiankang
Biogénesis-Bago
CAVAC
Rosenbusch
Agrovet
Vecol
CVCRI
IVPM
Prondil
CDV
Indian Immunologicals
Botswana Vaccine Institute
Ceva Santé Animale
Intervac
JOVAC
List of Tables
 Table 1. Global Biothrax (Anthrax Vaccine) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Biothrax (Anthrax Vaccine) Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Biothrax (Anthrax Vaccine) Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Biothrax (Anthrax Vaccine) Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Biothrax (Anthrax Vaccine) Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Biothrax (Anthrax Vaccine) Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Biothrax (Anthrax Vaccine) Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Biothrax (Anthrax Vaccine) Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Biothrax (Anthrax Vaccine), Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Biothrax (Anthrax Vaccine), Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Biothrax (Anthrax Vaccine), Product Type & Application
 Table 12. Global Key Manufacturers of Biothrax (Anthrax Vaccine), Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Biothrax (Anthrax Vaccine) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biothrax (Anthrax Vaccine) as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Biothrax (Anthrax Vaccine) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Biothrax (Anthrax Vaccine) Sales by Region (2020-2025) & (K Units)
 Table 18. Global Biothrax (Anthrax Vaccine) Sales Market Share by Region (2020-2025)
 Table 19. Global Biothrax (Anthrax Vaccine) Sales by Region (2026-2031) & (K Units)
 Table 20. Global Biothrax (Anthrax Vaccine) Sales Market Share by Region (2026-2031)
 Table 21. Global Biothrax (Anthrax Vaccine) Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Region (2020-2025)
 Table 23. Global Biothrax (Anthrax Vaccine) Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Region (2026-2031)
 Table 25. North America Biothrax (Anthrax Vaccine) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Biothrax (Anthrax Vaccine) Sales by Country (2020-2025) & (K Units)
 Table 27. North America Biothrax (Anthrax Vaccine) Sales by Country (2026-2031) & (K Units)
 Table 28. North America Biothrax (Anthrax Vaccine) Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Biothrax (Anthrax Vaccine) Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Biothrax (Anthrax Vaccine) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Biothrax (Anthrax Vaccine) Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Biothrax (Anthrax Vaccine) Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Biothrax (Anthrax Vaccine) Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Biothrax (Anthrax Vaccine) Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Biothrax (Anthrax Vaccine) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Biothrax (Anthrax Vaccine) Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Biothrax (Anthrax Vaccine) Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Biothrax (Anthrax Vaccine) Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Biothrax (Anthrax Vaccine) Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Biothrax (Anthrax Vaccine) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Biothrax (Anthrax Vaccine) Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Biothrax (Anthrax Vaccine) Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Biothrax (Anthrax Vaccine) Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Biothrax (Anthrax Vaccine) Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Biothrax (Anthrax Vaccine) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Biothrax (Anthrax Vaccine) Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Biothrax (Anthrax Vaccine) Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Biothrax (Anthrax Vaccine) Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Biothrax (Anthrax Vaccine) Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Biothrax (Anthrax Vaccine) Sales (K Units) by Type (2020-2025)
 Table 51. Global Biothrax (Anthrax Vaccine) Sales (K Units) by Type (2026-2031)
 Table 52. Global Biothrax (Anthrax Vaccine) Sales Market Share by Type (2020-2025)
 Table 53. Global Biothrax (Anthrax Vaccine) Sales Market Share by Type (2026-2031)
 Table 54. Global Biothrax (Anthrax Vaccine) Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Biothrax (Anthrax Vaccine) Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Type (2020-2025)
 Table 57. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Type (2026-2031)
 Table 58. Global Biothrax (Anthrax Vaccine) Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Biothrax (Anthrax Vaccine) Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Biothrax (Anthrax Vaccine) Sales (K Units) by Application (2020-2025)
 Table 61. Global Biothrax (Anthrax Vaccine) Sales (K Units) by Application (2026-2031)
 Table 62. Global Biothrax (Anthrax Vaccine) Sales Market Share by Application (2020-2025)
 Table 63. Global Biothrax (Anthrax Vaccine) Sales Market Share by Application (2026-2031)
 Table 64. Global Biothrax (Anthrax Vaccine) Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Biothrax (Anthrax Vaccine) Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Application (2020-2025)
 Table 67. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Application (2026-2031)
 Table 68. Global Biothrax (Anthrax Vaccine) Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Biothrax (Anthrax Vaccine) Price (US$/Unit) by Application (2026-2031)
 Table 70. Merial Company Information
 Table 71. Merial Description and Business Overview
 Table 72. Merial Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Merial Biothrax (Anthrax Vaccine) Product
 Table 74. Merial Recent Developments/Updates
 Table 75. Merck Company Information
 Table 76. Merck Description and Business Overview
 Table 77. Merck Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Merck Biothrax (Anthrax Vaccine) Product
 Table 79. Merck Recent Developments/Updates
 Table 80. Zoetis Company Information
 Table 81. Zoetis Description and Business Overview
 Table 82. Zoetis Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Zoetis Biothrax (Anthrax Vaccine) Product
 Table 84. Zoetis Recent Developments/Updates
 Table 85. Bayer Sanidad Animal Company Information
 Table 86. Bayer Sanidad Animal Description and Business Overview
 Table 87. Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Product
 Table 89. Bayer Sanidad Animal Recent Developments/Updates
 Table 90. Colorado Serum Company Information
 Table 91. Colorado Serum Description and Business Overview
 Table 92. Colorado Serum Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Colorado Serum Biothrax (Anthrax Vaccine) Product
 Table 94. Colorado Serum Recent Developments/Updates
 Table 95. PharmAthene Company Information
 Table 96. PharmAthene Description and Business Overview
 Table 97. PharmAthene Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. PharmAthene Biothrax (Anthrax Vaccine) Product
 Table 99. PharmAthene Recent Developments/Updates
 Table 100. Tiankang Company Information
 Table 101. Tiankang Description and Business Overview
 Table 102. Tiankang Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Tiankang Biothrax (Anthrax Vaccine) Product
 Table 104. Tiankang Recent Developments/Updates
 Table 105. Biogénesis-Bago Company Information
 Table 106. Biogénesis-Bago Description and Business Overview
 Table 107. Biogénesis-Bago Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Biogénesis-Bago Biothrax (Anthrax Vaccine) Product
 Table 109. Biogénesis-Bago Recent Developments/Updates
 Table 110. CAVAC Company Information
 Table 111. CAVAC Description and Business Overview
 Table 112. CAVAC Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. CAVAC Biothrax (Anthrax Vaccine) Product
 Table 114. CAVAC Recent Developments/Updates
 Table 115. Rosenbusch Company Information
 Table 116. Rosenbusch Description and Business Overview
 Table 117. Rosenbusch Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Rosenbusch Biothrax (Anthrax Vaccine) Product
 Table 119. Rosenbusch Recent Developments/Updates
 Table 120. Agrovet Company Information
 Table 121. Agrovet Description and Business Overview
 Table 122. Agrovet Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Agrovet Biothrax (Anthrax Vaccine) Product
 Table 124. Agrovet Recent Developments/Updates
 Table 125. Vecol Company Information
 Table 126. Vecol Description and Business Overview
 Table 127. Vecol Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Vecol Biothrax (Anthrax Vaccine) Product
 Table 129. Vecol Recent Developments/Updates
 Table 130. CVCRI Company Information
 Table 131. CVCRI Description and Business Overview
 Table 132. CVCRI Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. CVCRI Biothrax (Anthrax Vaccine) Product
 Table 134. CVCRI Recent Developments/Updates
 Table 135. IVPM Company Information
 Table 136. IVPM Description and Business Overview
 Table 137. IVPM Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. IVPM Biothrax (Anthrax Vaccine) Product
 Table 139. IVPM Recent Developments/Updates
 Table 140. Prondil Company Information
 Table 141. Prondil Description and Business Overview
 Table 142. Prondil Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Prondil Biothrax (Anthrax Vaccine) Product
 Table 144. Prondil Recent Developments/Updates
 Table 145. CDV Company Information
 Table 146. CDV Description and Business Overview
 Table 147. CDV Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. CDV Biothrax (Anthrax Vaccine) Product
 Table 149. CDV Recent Developments/Updates
 Table 150. Indian Immunologicals Company Information
 Table 151. Indian Immunologicals Description and Business Overview
 Table 152. Indian Immunologicals Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Indian Immunologicals Biothrax (Anthrax Vaccine) Product
 Table 154. Indian Immunologicals Recent Developments/Updates
 Table 155. Botswana Vaccine Institute Company Information
 Table 156. Botswana Vaccine Institute Description and Business Overview
 Table 157. Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Product
 Table 159. Botswana Vaccine Institute Recent Developments/Updates
 Table 160. Ceva Santé Animale Company Information
 Table 161. Ceva Santé Animale Description and Business Overview
 Table 162. Ceva Santé Animale Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 163. Ceva Santé Animale Biothrax (Anthrax Vaccine) Product
 Table 164. Ceva Santé Animale Recent Developments/Updates
 Table 165. Intervac Company Information
 Table 166. Intervac Description and Business Overview
 Table 167. Intervac Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 168. Intervac Biothrax (Anthrax Vaccine) Product
 Table 169. Intervac Recent Developments/Updates
 Table 170. JOVAC Company Information
 Table 171. JOVAC Description and Business Overview
 Table 172. JOVAC Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 173. JOVAC Biothrax (Anthrax Vaccine) Product
 Table 174. JOVAC Recent Developments/Updates
 Table 175. Key Raw Materials Lists
 Table 176. Raw Materials Key Suppliers Lists
 Table 177. Biothrax (Anthrax Vaccine) Distributors List
 Table 178. Biothrax (Anthrax Vaccine) Customers List
 Table 179. Biothrax (Anthrax Vaccine) Market Trends
 Table 180. Biothrax (Anthrax Vaccine) Market Drivers
 Table 181. Biothrax (Anthrax Vaccine) Market Challenges
 Table 182. Biothrax (Anthrax Vaccine) Market Restraints
 Table 183. Research Programs/Design for This Report
 Table 184. Key Data Information from Secondary Sources
 Table 185. Key Data Information from Primary Sources
 Table 186. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Biothrax (Anthrax Vaccine)
 Figure 2. Global Biothrax (Anthrax Vaccine) Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Biothrax (Anthrax Vaccine) Market Share by Type: 2024 & 2031
 Figure 4. Live Vaccines Product Picture
 Figure 5. Cell Free PA Vaccines Product Picture
 Figure 6. Global Biothrax (Anthrax Vaccine) Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Biothrax (Anthrax Vaccine) Market Share by Application: 2024 & 2031
 Figure 8. Human Use
 Figure 9. Animal Use
 Figure 10. Global Biothrax (Anthrax Vaccine) Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Biothrax (Anthrax Vaccine) Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Biothrax (Anthrax Vaccine) Sales (2020-2031) & (K Units)
 Figure 13. Global Biothrax (Anthrax Vaccine) Average Price (US$/Unit) & (2020-2031)
 Figure 14. Biothrax (Anthrax Vaccine) Report Years Considered
 Figure 15. Biothrax (Anthrax Vaccine) Sales Share by Manufacturers in 2024
 Figure 16. Global Biothrax (Anthrax Vaccine) Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Biothrax (Anthrax Vaccine) Players: Market Share by Revenue in Biothrax (Anthrax Vaccine) in 2024
 Figure 18. Biothrax (Anthrax Vaccine) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Biothrax (Anthrax Vaccine) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Biothrax (Anthrax Vaccine) Sales Market Share by Country (2020-2031)
 Figure 21. North America Biothrax (Anthrax Vaccine) Revenue Market Share by Country (2020-2031)
 Figure 22. United States Biothrax (Anthrax Vaccine) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Biothrax (Anthrax Vaccine) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Biothrax (Anthrax Vaccine) Sales Market Share by Country (2020-2031)
 Figure 25. Europe Biothrax (Anthrax Vaccine) Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Biothrax (Anthrax Vaccine) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Biothrax (Anthrax Vaccine) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Biothrax (Anthrax Vaccine) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Biothrax (Anthrax Vaccine) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Biothrax (Anthrax Vaccine) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Biothrax (Anthrax Vaccine) Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Biothrax (Anthrax Vaccine) Revenue Market Share by Region (2020-2031)
 Figure 33. China Biothrax (Anthrax Vaccine) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Biothrax (Anthrax Vaccine) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Biothrax (Anthrax Vaccine) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Biothrax (Anthrax Vaccine) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Biothrax (Anthrax Vaccine) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Biothrax (Anthrax Vaccine) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Biothrax (Anthrax Vaccine) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Biothrax (Anthrax Vaccine) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Biothrax (Anthrax Vaccine) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Biothrax (Anthrax Vaccine) Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Biothrax (Anthrax Vaccine) Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Biothrax (Anthrax Vaccine) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Biothrax (Anthrax Vaccine) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Biothrax (Anthrax Vaccine) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Biothrax (Anthrax Vaccine) Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Biothrax (Anthrax Vaccine) Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Biothrax (Anthrax Vaccine) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Biothrax (Anthrax Vaccine) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Biothrax (Anthrax Vaccine) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Biothrax (Anthrax Vaccine) by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Biothrax (Anthrax Vaccine) by Type (2020-2031)
 Figure 54. Global Biothrax (Anthrax Vaccine) Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Biothrax (Anthrax Vaccine) by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Biothrax (Anthrax Vaccine) by Application (2020-2031)
 Figure 57. Global Biothrax (Anthrax Vaccine) Price (US$/Unit) by Application (2020-2031)
 Figure 58. Biothrax (Anthrax Vaccine) Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Veterinary Anthrax Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anthrax Vaccines Market Insights Forecast to 2030
Anthrax Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Abthrax Market Insights Forecast to 2030
Global Bacterial Vaccines for Humans Market Research Report 2024
Cattle and Sheep Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Global Human Vaccination Market Research Report 2025
Human Rabies Vaccine Vero Cell Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Ruminant Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Animal Vaccines Market Insights Forecast to 2030
Farm Animal Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vaccines for Livestock Farming Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Disease Control and Prevention Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Veterinary Biological Vaccines Market Research Report 2025
Global Human Rabies Vaccine Market Research Report 2024
TB Vaccine Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Brucellosis Vaccines Market Research Report 2025
Global TB Vaccines Market Insights Forecast to 2030
Global BCG Vaccine Market Insights Forecast to 2030

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions